TMC Life Sciences Berhad (0101.KL)
MYR 0.49
(-1.01%)
MYR 0.49
(-1.01%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 80.22 Million | 54.57 Million | 35.87 Million | 22.44 Million | 18.08 Million | 30.19 Million |
| Net Income | 40.64 Million | 40.89 Million | 32.18 Million | 27.67 Million | 15.93 Million | 38.15 Million |
| Depreciation & Amortization | 27.91 Million | 26 Million | 15.85 Million | 13.02 Million | 11.93 Million | 11.2 Million |
| Deferred income taxes | - | -7.7 Million | -10.48 Million | -6.08 Million | - | -10.19 Million |
| Stock-based compensation | 55 Thousand | 127 Thousand | 236 Thousand | 202 Thousand | - | 183 Thousand |
| Change in working capital | 241 Thousand | -10.9 Million | -1.98 Million | -10.58 Million | -3.09 Million | -1.84 Million |
| Other non-cash items | 56.88 Million | 6.15 Million | 78 Thousand | -1.77 Million | 20.26 Million | -7.3 Million |
| Investing Cash Flow | -59.6 Million | -38.92 Million | -74.35 Million | -96.13 Million | -98.1 Million | 9.42 Million |
| Investments in PPE | -28.54 Million | -34.45 Million | -68.68 Million | -103.52 Million | -136.55 Million | -61.51 Million |
| Acquisitions | - | 4000.00 | - | 23 Thousand | 5000.00 | - |
| Investment purchases | -31.05 Million | -5.82 Million | -7.29 Million | 867 Thousand | - | - |
| Sales/Maturities of investments | - | 2.49 Million | - | 6.57 Million | 38.45 Million | 63.54 Million |
| Other Investing Activities | -36 Thousand | -1.13 Million | 1.62 Million | -71 Thousand | - | 7.39 Million |
| Financing Cash Flow | -29.65 Million | 2.04 Million | 32.04 Million | 82.31 Million | 75.2 Million | 809 Thousand |
| Debt repayment | -13 Million | -7.59 Million | -98 Thousand | -65 Thousand | -79.99 Million | -65 Thousand |
| Dividends payments | -14.62 Million | -4.81 Million | -3.85 Million | -2.92 Million | -3.5 Million | -3.17 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 4.07 Million |
| Other Financing Activities | -2.02 Million | 14.44 Million | 35.99 Million | 85.29 Million | - | 4.05 Million |
| Accounts receivables | 8.74 Million | -21.06 Million | -14.6 Million | -1.45 Million | 7.55 Million | -3.74 Million |
| Accounts payables | 8.74 Million | 13.33 Million | 13.41 Million | -10.17 Million | -10.01 Million | 2.78 Million |
| Inventory | 1.61 Million | -3.17 Million | -787 Thousand | 1.04 Million | -635 Thousand | -891 Thousand |
| Other working capital | -10.12 Million | - | - | - | - | - |
| Cash at beginning of period | 120.74 Million | 98.88 Million | 105.32 Million | 96.69 Million | 102.02 Million | 61.09 Million |
| Cash at end of period | 111.71 Million | 116.57 Million | 98.88 Million | 105.32 Million | 97.19 Million | 101.51 Million |
| Capital Expenditure | -28.54 Million | -34.45 Million | -68.68 Million | -103.52 Million | -136.55 Million | -61.51 Million |
| Effect of forex changes on cash | - | - | - | 2000.00 | -12 Thousand | -3000.00 |
| Net cash flow / Change in cash | -9.03 Million | 17.69 Million | -6.44 Million | 8.63 Million | -4.82 Million | 40.41 Million |
| Free Cash Flow | 51.68 Million | 20.11 Million | -32.81 Million | -81.07 Million | -118.47 Million | -31.32 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.02 Million | 40.64 Million | 9.96 Million | 14.52 Million | 20.14 Million | 40.89 Million |
| Depreciation & Amortization | 7.55 Million | 27.91 Million | 6.92 Million | 6.64 Million | 6.79 Million | 26 Million |
| Deferred income taxes | - | - | - | - | - | -7.7 Million |
| Stock-based compensation | - | 55 Thousand | - | - | - | 127 Thousand |
| Change in working capital | 3.56 Million | 241 Thousand | -2.51 Million | 3.04 Million | -3.85 Million | -10.9 Million |
| Other non-cash items | -1.46 Million | 56.88 Million | 20.16 Million | 5.22 Million | -846 Thousand | 6.15 Million |
| Investing Cash Flow | -10.07 Million | -59.6 Million | -31.99 Million | -13.18 Million | -3.07 Million | -38.92 Million |
| Investments in PPE | -9.83 Million | -28.54 Million | -10.19 Million | -4.16 Million | -4.34 Million | -34.45 Million |
| Acquisitions | - | - | - | - | - | 4000.00 |
| Investment purchases | -237 Thousand | -31.05 Million | -21.79 Million | -9.02 Million | - | -5.82 Million |
| Sales/Maturities of investments | - | - | - | - | - | 2.49 Million |
| Other Investing Activities | -1.64 Million | -36 Thousand | - | -1.00 | 1.27 Million | -1.13 Million |
| Financing Cash Flow | -4.51 Million | -29.65 Million | -4.5 Million | -16.14 Million | -4.49 Million | 2.04 Million |
| Debt repayment | -3.98 Million | -13 Million | -3.99 Million | -1.02 Million | -3.77 Million | -7.59 Million |
| Dividends payments | - | -14.62 Million | - | -14.62 Million | - | -4.81 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -523 Thousand | - | - | - | -718 Thousand | 14.44 Million |
| Accounts receivables | - | - | - | - | - | -21.06 Million |
| Accounts payables | 14.87 Million | 8.74 Million | -3.84 Million | 205 Thousand | -2.49 Million | 13.33 Million |
| Inventory | - | 1.61 Million | - | - | - | -3.17 Million |
| Other working capital | -12.93 Million | -10.12 Million | 1.32 Million | 2.84 Million | -1.35 Million | - |
| Cash at beginning of period | 115.85 Million | 120.74 Million | 135.5 Million | 135.4 Million | 116.57 Million | 98.88 Million |
| Cash at end of period | 111.71 Million | 111.71 Million | 115.85 Million | 135.5 Million | 131.24 Million | 116.57 Million |
| Capital Expenditure | -9.83 Million | -28.54 Million | -10.19 Million | -4.16 Million | -4.34 Million | -34.45 Million |
| Effect of forex changes on cash | - | - | - | -1.00 | - | - |
| Net cash flow / Change in cash | -4.14 Million | -9.03 Million | -19.65 Million | 100 Thousand | 14.66 Million | 17.69 Million |
| Free Cash Flow | 603 Thousand | 51.68 Million | 6.64 Million | 25.27 Million | 17.88 Million | 20.11 Million |
CFNB
3626
BXPHF
CV
SIGIND
AXTA